Analgesic Effect of SKI306X on Chronic Postischemic Pain and Spinal Nerve Ligation-Induced Neuropathic Pain in Mice

Jie Quan,Chun Jing He,Ji Yeon Kim,Jin Young Lee,Chang Jae Kim,Young Jae Jeon,Chang Woo Im,Do Kyung Lee,Ji Eun Kim,Hue Jung Park

DOI: https://doi.org/10.3390/biomedicines12071379

IF: 4.757

2024-06-22

Biomedicines

Abstract:Neuropathic pain (NP) results from lesions or diseases affecting the peripheral or central somatosensory system. However, there are currently no drugs that are particularly effective in treating this condition. SKI306X is a blend of purified extracts of three oriental herbs (Clematis mandshurica, Trichosanthes kirilowii, and Prunella vulgaris) commonly used to treat osteoarthritis for their chondroprotective effects. Chronic postischemic pain (CPIP) and spinal nerve ligation (SNL) models were created by binding the upper left ankle of mice with an O-ring for 3 h and ligating the L5 spinal nerve, respectively. Mice with allodynia were injected intraperitoneally with 0.9% normal saline (NS group) or different doses (25, 50, or 100 mg/kg) of SKI306X (SKI groups). We assessed allodynia using von Frey filaments before injection and 30, 60, 90, 120, 180, and 240 min and 24 h after injection to confirm the antiallodynic effect of SKI306X. We also measured glial fibrillary acidic protein (GFAP) levels in the spinal cord and dorsal root ganglia to confirm the change of SKI306X administration. Both models exhibited significant mechanical allodynia. The intraperitoneal injection of SKI306X significantly increased the paw withdrawal threshold in a dose-dependent manner, as the paw withdrawal threshold was significantly increased after SKI306X administration compared with at baseline or after NS administration. GFAP levels in the SKI group decreased significantly (p < 0.05). Intraperitoneal administration of SKI306X dose-dependently attenuated mechanical allodynia and decreased GFAP levels, suggesting that GFAP is involved in the antiallodynic effect of SKI306X in mice with CPIP and SNL-induced NP.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the effective treatment of neuropathic pain (NP). Neuropathic pain is caused by damage or disease in the peripheral or central sensory systems, and currently there is a lack of particularly effective treatment methods. The paper mentions that existing therapeutic drugs may lead to drug resistance and adverse reactions of different degrees when used for a long time, and the overall curative effect is not satisfactory. Therefore, exploring new effective treatment measures is of great significance for medicine and society.

Specifically, the paper studied the analgesic effect of SK306X in mouse models of chronic post - ischemic pain (CPIP) and neuropathic pain induced by spinal nerve ligation (SNL). SK306X is a mixture composed of purified extracts of three oriental herbs (Clematis mandshurica, Trichosanthes kirilowii, and Prunella vulgaris) and is often used to treat osteoarthritis. By establishing CPIP and SNL models, the study evaluated the effects of different doses of SK306X on mechanical allodynia and detected the changes in the level of glial fibrillary acidic protein (GFAP) in the spinal cord and dorsal root ganglia to explore the anti - allodynic effect of SK306X and its possible mechanisms.